Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
Journal of Child and Adolescent Psychopharmacology|April 22, 2026
Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase)Basile Chrétien, Camille Blouet, Joachim Alexandre, et al.
European Journal of Clinical Pharmacology|August 25, 2015
Rivaroxaban-induced hair lossBasile Chrétien, Anne Besnard, Marion Sassier, et al.
Intensive Care Medicine|December 1, 2017
Is ticagrelor safe in intensive care unit patients? Focus on bradycardic eventsXavier Valette, Suzanne Goursaud, Joachim Alexandre, et al.
Journal of the American Academy of Dermatology|September 15, 2019
Thiazides and nonmelanoma skin cancer: Is it a class effect?Xavier Humbert, Charles Dolladille, Basile Chrétien, et al.
Autoimmunity Reviews|July 28, 2022
Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance databaseAnaël Dumont, Charles Dolladille, Hubert de Boysson, et al.
Journal of Hypertension|May 31, 2018
Office white-coat effect tail and long-term cardiovascular risks in the Gubbio residential cohort studyXavier Humbert, Sophie Fedrizzi, Joachim Alexandre, et al.
Journal of Neurology|December 16, 2025
Guillain-Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance studyJean Cabon, Mathilde Ducloie, Basile Chretien, et al.
Journal of Hypertension|September 1, 2017
Aldoscore to predict postoperative atrial fibrillation after cardiac surgery: external validation in a Japanese cohortJoachim Alexandre, Akira Sezai, Stéphane Allouche, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 7, 2021
Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database AnalysisCharles Dolladille, Basile Chrétien, Laure Peyro-Saint-Paul, et al.
Clinical Pharmacology and Therapeutics|June 13, 2023
Hypoxia Associated With Dihydropyridine Calcium Channel Inhibitors: A Pharmacovigilance Study in VigiBaseBasile Chrétien, Jean Baptiste Decros, Florimond Suard, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
Journal of Child and Adolescent Psychopharmacology|April 22, 2026
Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase)Basile Chrétien, Camille Blouet, Joachim Alexandre, et al.
European Journal of Clinical Pharmacology|August 25, 2015
Rivaroxaban-induced hair lossBasile Chrétien, Anne Besnard, Marion Sassier, et al.
Intensive Care Medicine|December 1, 2017
Is ticagrelor safe in intensive care unit patients? Focus on bradycardic eventsXavier Valette, Suzanne Goursaud, Joachim Alexandre, et al.
Journal of the American Academy of Dermatology|September 15, 2019
Thiazides and nonmelanoma skin cancer: Is it a class effect?Xavier Humbert, Charles Dolladille, Basile Chrétien, et al.
Autoimmunity Reviews|July 28, 2022
Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance databaseAnaël Dumont, Charles Dolladille, Hubert de Boysson, et al.
Journal of Hypertension|May 31, 2018
Office white-coat effect tail and long-term cardiovascular risks in the Gubbio residential cohort studyXavier Humbert, Sophie Fedrizzi, Joachim Alexandre, et al.
Journal of Neurology|December 16, 2025
Guillain-Barré syndrome associated with immune checkpoint inhibitors exposure: a pharmacovigilance studyJean Cabon, Mathilde Ducloie, Basile Chretien, et al.
Journal of Hypertension|September 1, 2017
Aldoscore to predict postoperative atrial fibrillation after cardiac surgery: external validation in a Japanese cohortJoachim Alexandre, Akira Sezai, Stéphane Allouche, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 7, 2021
Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database AnalysisCharles Dolladille, Basile Chrétien, Laure Peyro-Saint-Paul, et al.
Clinical Pharmacology and Therapeutics|June 13, 2023
Hypoxia Associated With Dihydropyridine Calcium Channel Inhibitors: A Pharmacovigilance Study in VigiBaseBasile Chrétien, Jean Baptiste Decros, Florimond Suard, et al.
Pageof 15